| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2837048 | Cardiovascular Revascularization Medicine | 2013 | 5 Pages |
Abstract
Congestive heart failure (CHF) secondary to ischemic cardiomyopathy is associated with significant morbidity and mortality despite currently available medical therapy. The ParachuteTM device is a novel left ventricular partitioning device that is delivered percutaneously in the left ventricle (LV) in patients with anteroapical regional wall motion abnormalities, dilated LV and systolic dysfunction after anterior myocardial infarction with favorable clinical and LV hemodynamic improvements post-implantation. Here, we do review the current literature and present a case of the Parachute device implantation.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Molecular Medicine
Authors
Mehmet Cilingiroglu, William A. Rollefson, David Mego,